BPC-157: The Promise and Perils of a Healing Peptide cover art

BPC-157: The Promise and Perils of a Healing Peptide

Preview
Try Standard free
Select 1 audiobook a month from our entire collection.
Listen to your selected audiobooks as long as you're a member.
Get unlimited access to bingeable podcasts.
Auto-renews at $8.99/mo after 30 days. Cancel anytime.

BPC-157: The Promise and Perils of a Healing Peptide

By: Alex Apple
Narrated by: Solly Vo
Try Standard free

Auto-renews at $8.99/mo after 30 days. Cancel anytime.

Buy Now for $9.68

Buy Now for $9.68

About this listen

BPC-157: The Promise and Perils of a Healing Peptide is a clear-eyed exploration of one of the most talked-about compounds in modern recovery and biohacking. Originally studied for its potential effects on tissue repair and gut health, BPC-157 has drawn attention for its reported ability to support tendon healing, inflammation reduction, and recovery. While promising animal research has fueled interest, the absence of large-scale human trials leaves important questions about safety, regulation, and long-term effects.

In this balanced and accessible guide, Alex Apple examines the science behind BPC-157, how it’s being used in real-world settings, and the risks that are often overlooked. Rather than promoting hype or fear, this audiobook offers a practical, research-informed look at what is known, what isn’t, and what listeners should consider before drawing conclusions. Part of the Promise & Perils series, this audiobook is designed for listeners who want thoughtful, nuanced perspectives on emerging health and longevity topics. Narrated by Solly Vo

©2025, 2026 Alex Apple (P)2026 Alex Apple
Medicine & Health Care Industry Pharmacology
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.